Katy Bernard

Temporal binding function of dorsal CA1 is critical for declarative memory formation

Azza Sellami, Alice Shaam Al Abed, Laurent Brayda-Bruno et al. · Proceedings of the National Academy of Sciences · 2017 · 44 citations · Full text

Neuropsychology, Dorsal Ca1, Aging +20

Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial

Thomas J. Schnitzer, María Pueyo, H. Deckx et al. · Osteoarthritis and Cartilage · 2023 · 38 citations · Full text

DRUG FOCUS: S 18986: A Positive Allosteric Modulator of AMPA‐Type Glutamate Receptors Pharmacological Profile of a Novel Cognitive Enhancer

Katy Bernard, Laurence Danober, Jean‐Yves Thomas et al. · CNS Neuroscience & Therapeutics · 2010 · 35 citations · Full text

Novel Cognitive Enhancer, Synaptic Transmission, Neurotransmitter +19

Impact of peritoneal tears on the outcome and late results (4 years) of endoscopic totally extra-peritoneal inguinal hernioplasty

Giuliana Muzio, Katy Bernard, C. Polliand et al. · Hernia · 2006 · 30 citations

Late Results, Hernia Surgery, Gynecology +4

NEUROPHARMACOKINETICS OF A NEW α-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC ACID (AMPA) MODULATOR, S18986 [(S)-2,3-DIHYDRO-[3,4]CYCLOPENTANO-1,2,4-BENZOTHIADIAZINE-1,1-DIOXIDE], IN THE RAT

Fanchon Bourasset, Katy Bernard, Carmen Muñoz et al. · Drug Metabolism and Disposition · 2005 · 26 citations